Our Impact
Effective mental health care needs innovative research that is embedded in the real world. On these pages you can explore the impact of the NIHR Biomedical Research Centre: Maudsley and how we are making a difference to people’s lives, today and tomorrow.
Impact stories
1-4 of 4 impact stories
Point-of-care testing to enable patients to access clozapine
Experimental Medicine and Novel Therapeutics
New non-sedating drug treatment for anxiety disorders
Experimental Medicine and Novel Therapeutics
Psilocybin-assisted therapy for depression
Experimental Medicine and Novel Therapeutics
Using ketamine to test new drug therapies for schizophrenia
Experimental Medicine and Novel Therapeutics£50M
NIHR Funding Award (2022 - 2028)
The NIHR awarded the NIHR BRC: Maudsley funding in 2022 to continue our work developing better and more targeted treatments in brain and mental health.